CEL-SCI Announces Pricing of $2.5 Million Offering
1. CVM prices a $2.5 million offering, potentially affecting funding for operations. 2. This offering may dilute current share value, impacting investor sentiment.
1. CVM prices a $2.5 million offering, potentially affecting funding for operations. 2. This offering may dilute current share value, impacting investor sentiment.
Offerings typically dilute existing shares, impacting long-term value. Historical trends show price drops post-offering announcements.
The offering may signal cash flow needs, influencing investor perception of CVM's financial health.
Initial market reaction to offering could result in immediate price adjustments. Similar offerings have caused short-term declines in biotech stocks.